¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"high mannose oligosaccharide"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • membrane-derived oligosaccharide
    ¼¼Æ÷¸·À¯·¡¼Ò´ç·ù, ¼¼Æ÷¸·À¯·¡¿Ã¸®°í´ç·ù
  • oligosaccharide
    ¼Ò´ç·ù, ¿Ã¸®°í´ç·ù
  • high altitude
    °íÁö-, °í¼Ò-
  • high altitude illness
    °í¼Òº´
  • high altitude polycythemia
    ³ôÀº°÷ÀûÇ÷±¸Áõ°¡Áõ
  • high altitude pulmonary edema
    °íÁö´ëÆóºÎÁ¾
  • high density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹éÁú
  • high dose rate
    °í¼±·®·ü
  • high dose rate intraluminal radiotherapy
    °í¼±·®·ü°ü³»¹æ»ç¼±Ä¡·á
  • high dose tolerance
    Ç׿ø°ú·®Çã¿ë
  • high energy bond
    °í¿¡³ÊÁö°áÇÕ
  • high energy compound
    °í¿¡³ÊÁöÈ­ÇÕ¹°
  • high energy phosphate compound
    °í¿¡³ÊÁöÀλ꿰ȭÇÕ¹°
  • high field magnetic resonance scanner
    °íÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • high flow method
    °íÀ¯·®¹ý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oligosaccharide
    ¼Ò´ç·ù, ¿Ã¸®°í´ç·ù
  • high altitude
    °íÁö-, °í¼Ò-
  • high risk group
    °íÀ§Ç豺
  • high-dose
    °í¿ë·®
  • high density lipoprotein
    °í¹ÐµµÁöÁú´Ü¹é
  • high grade squamous intraepithelial lesion
    °íµî±ÞÆíÆò»óÇdz»º´ÅÍ
  • high potency
    °íÈ¿´É, °í¿ª°¡, °íÀáÀç·Â
  • high resolution computed tomography
    °íÇØ»óÀü»ê´ÜÃþÃÔ¿µ¼ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • membrane-derived oligosaccharide
    ¼¼Æ÷¸·À¯·¡¼Ò´ç·ù
  • oligosaccharide
    ¼Ò´ç·ù, ¿Ã¸®°í´ç·ù
  • high power application
    °íÃâ·ÂÀû¿ë
  • high spatial frequency algorithm
    °í°ø°£Á֯ļö¿¬»ê
  • high energy bond
    °í¿¡³ÊÁö°áÇÕ
  • high speed core cut biopsy
    °í¼ÓÁ߽ɻý°Ë
  • high frequency current
    °íÁÖÆÄÀü·ù
  • high polymer chemistry
    °íºÐÀÚÈ­ÇÐ
  • high-performance liquid chromatography
    °íÀÛÀ§¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • high-pressure liquid chromatography
    °í¾Ð·Â¾×üũ·Î¸¶Åä±×·¡ÇÇ
  • high-threshold cell
    °í¹®Åΰª¼¼Æ÷
  • high forceps delivery
    °íÀ§Áý°ÔºÐ¸¸¼ú
  • high residue diet
    °íÀÜ·ù½ÄÀÌ
  • high tone deafness
    °íÀ½³­Ã»
  • high altitude pulmonary edema
    °í»êÆóºÎÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • GDPM= guanosine diphosphate mannose
    ±¸¾Æ³ë½ÅÀÌÀλ길³ë¿ÀÁ¦.
  • guanosine diphosphate mannose =GDPM
    ÀÌÀλ길³ë½º±¸¾Æ³ë½Å.
  • HDL (High-density lipoproteins)
    °í¹ÐµµÁö´Ü¹éÁú(ÍÔÚËÓøò·Ó±ÛÜòõ)
  • High energy phosphate
    °í¿¡³ÊÁöÀλê
  • High intensity proton flow
    °í°­µµ ¾çÀÚ À¯µ¿
  • High-density lipoprotein = HDL
    °í¹ÐµµÁö´Ü¹éÁú(ÍÔÚËÓøò·Ó±ÛÜòõ)
  • High-molecular-weight kininogen
    °íºÐÀÚ·®Å°´Ï³ëÁø
  • High-threshold cells
    °í¿ªÄ¡¼¼Æ÷(ÍÔ ö·á¬øà)
  • high altitude
    °í¼Ò
  • high altitude polycyth(a)emia
    °í¼Ò¼º ÀûÇ÷±¸Áõ°¡(Áõ)(ÍÔá¶àõîåúìϹñòÊ¥ñø) .
  • high altitude polycyth(a)emia
    °í¼Ò¼º ÀûÇ÷±¸Áõ°¡(Áõ)(Ë­ËÛËÛËøÌ´Ë´Ì¡?Ì¡) .
  • high altitude pulmonary edema
    °íÁöÆóºÎÁ¾.
  • high caloric diet
    °íÄ®·Î¸®½ÄÀÌ.
  • high cellular component
    °í¼¼Æ÷ ±¸¼º ¼ººÐ
  • high dizziness
    °í¼ÒÇö±âÁõ(Ë­ËÛ̴˻̡).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • guanosine diphosphate mannose =GDPM
    ÀÌÀλ길³ë½º±¸¾Æ³ë½Å.
  • mannose
    ¸¸³ë½º.
  • determinant, oligosaccharide
    °¨´ç·ùÇ׿ø°áÁ¤±â
  • membrane-derived oligosaccharide
    ¼¼Æ÷¸·À¯·¡ ¼Ò´ç·ù
  • oligosaccharide
    °ú´çÁú.
  • oligosaccharide
    ¿Ã¸®°í´ç
  • familial high density lipoprotein def
    °¡Á·¼º °íºñÁ߸®Æ÷´Ü¹éÁú°áÇÌ Áõ.
  • high altitude
    °í¼Ò
  • high altitude polycyth(a)emia
    °í¼Ò¼º ÀûÇ÷±¸Áõ°¡(Áõ)(Ë­ËÛËÛËøÌ´Ë´Ì¡?Ì¡) .
  • high altitude polycyth(a)emia
    °í¼Ò¼º ÀûÇ÷±¸Áõ°¡(Áõ)(ÍÔá¶àõîåúìϹñòÊ¥ñø) .
  • high altitude pulmonary edema
    °íÁöÆóºÎÁ¾.
  • high caloric diet
    °íÄ®·Î¸®½ÄÀÌ.
  • high cellular component
    °í¼¼Æ÷ ±¸¼º ¼ººÐ
  • high dizziness
    °í¼ÒÇö±âÁõ(Ë­ËÛ̴˻̡).
  • high dose rate
    °í¼±·®À²
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high-mannose glycoproteins
    ´Ù(Òý)¸¸³ë½º ´ç´Ü¹éÁú(ÓØÓ±ÛÜòõ)
  • high-mannose oligosaccharides
    ´Ù(Òý)¸¸³ë½º °ú´çÁú(ÍûÓØòõ)
  • mannose
    ¸¸³ë½º
  • N-linked oligosaccharide
    N-¿¬°á ¿Ã¸®°í´çÁú(ÓØòõ)
  • oligosaccharide
    °ú´çÁú(ÍûÓØòõ)
  • O-linked oligosaccharide
    O-°áÇÕ°ú´çÁú(Ì¿ùêÍûÓØòõ)
  • familial high-density lipoprotein deficiency °¡Á·¼º °í¹Ðµµ ÁöÁú´Ü¹éÁú °áÇÌ (Ê«ðéàõÍÔÚËÓøò·òõ
    Ó±ÛÜòõÌÀù¹)
  • high-density lipoprotein
    °í¹Ðµµ ÁöÁú´Ü¹éÁú(ÍÔÚËÓøò·òõÓ±ÛÜòõ)
  • high-energy bond
    °í(ÍÔ)¿¡³ÊÁö °áÇÕ(Ì¿ùê)
  • high-energy compound
    °í(ÍÔ)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • high-energy ion scattering
    °í(ÍÔ)¿¡³ÊÁö À̿»ê¶õ(ߤկ)
  • high-energy phosphate donor
    °í(ÍÔ)¿¡³ÊÁö ÀÎ»ê°ø¿©ÀÚ(×òß«Íêæ¨í­)
  • high-level promoter
    °íÀ§(ÍÔêÈ)ÇÁ·Î¸ðÅÍ
  • high-lipid lipoprotein
    °íÁöÁú ÁöÁú´Ü¹éÁú(ÍÔò·òõò¢òõÓ±ÛÜòõ)
  • high-mobility group
    °íÀ̵¿µµ ±º(ÍÔì¹ÔÑÓøÏØ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • high cellular component
    °í¼¼Æ÷±¸¼º¼ººÐ
  • high echo area
    °í¿¡ÄÚ ±¸¿ª
  • high energy
    °í¿¡³ÊÁö
  • high energy radiation
    °íÀü¾ÐÁ¶»ç
  • high field MR scanner
    °íÀÚÀå ÀÚ±â°ø¸í½ºÄ³³Ê
  • high frequency
    °íºóµµ, °íÁÖÆÄ
  • high intensity proton flow
    °í°­µµ¾çÀÚÀ¯µ¿
  • high output heart failure
    °í¹ÚÃ⼺½ÉºÎÀü
  • high power application
    °íÃâ·ÂÀû¿ë
  • high protein diet
    °í´Ü¹é½ÄÀÌ
  • high quality scanning
    °íÁúÀÇ ½ºÄ³´×
  • high resolution
    °íÇØ»ó(µµ)
  • high resolution computed tomography [=HRCT]
    °íÇØ»óÀü»êÈ­´ÜÃþÃÔ¿µ¼ú
  • high risk group
    °íÀ§Çèµµ±º
  • high signal
    °í½ÅÈ£
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
HP halogen phosphorus; handicapped person; haptoglobin; hard palate; Harvard pump; health profession(al...
FTO fructose-terminated oligosaccharide
LOS length of stay; Licentiate in Obstetrical Science; lipo-oligosaccharide; low cardiac output syndrome...
HF Hageman factor; haplotype frequency; hard filled [capsule]; hay fever; head of fetus; head forward; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
LCO lipo-chitin oligosaccharide
LOS Lipo-oligosaccharide
OS Oligosaccharide
Man D-mannose
MS D-mannose-sensitive
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • oligosaccharide
    °¨´ç·ù, °ú´ç·ù, ¼Ò´ç·ù, ¿Ã¸®°í´ç
    °¡¼öºÐÇØ·Î ¼Ò¼ö
  • admixed high-copper alloy
    È¥ÇÕÇü °íµ¿ÇÕ±Ý
    °íµ¿ÇÕ±ÝÀÇ °¡Àå ¿À·¡µÈ ÇüÅ·μ­ Àº, ÁÖ¼®, 6% ÀÌÇÏÀÇ ±¸¸®¸¦ ÇÔÀ¯ÇÑ Àç·¡Çü Àúµ¿ÇԱݰú ´ë°Ô ±¸¸®°¡ ¸¹Àº Àº-±¸¸® °øÁ¤ ÇÕ±ÝÀÇ µÎ °¡Áö ºÐ¸»À» È¥ÇÕÇÏ¿© ±¸¸®ÀÇ ÃÑ·®À» Áõ°¡½ÃŲ °ÍÀÌ´Ù. Àúµ¿ Àç·¡Çü ÇÕ±ÝÀº Àý»èÇüÀÌ¸ç °íµ¿ÇÕ±ÝÀº ±¸»óÇüÀ̾ °á°úÀûÀ¸·Î Àý»èÇü°ú ±¸»óÇüÀÌ È¥ÇÕµÈ °ÍÀÌ´Ù.
  • high arched
    ³ôÀº ±¸°³±Ã
  • high cellular component
    °í¼¼Æ÷ ±¸¼º ¼ººÐ
  • high condylectomy
    °í °úµÎ ÀýÁ¦¼ú, »ó°úµÎ ÀýÁ¦¼ú
    »ó,ÇÏ¾Ç °úµÎÀÇ ÀϺκи¸À» ¿Ü°úÀûÀ¸·Î Á¦°ÅÇÏ´Â °Í.
  • high copper amalgam
    °íµ¿ ¾Æ¸»°¨
    ¾Æ¸»°¨ Çձݿ¡¼­ ±¸¸®ÀÇ ºñ°¡ ³ôÀº °Í.
  • high dose tolerance
    °í¿ª ¿ªÄ¡
  • high electron density
    °íÀüÀÚ ¹Ðµµ
    ÀüÀÚµéÀÇ ¹Ðµµ°¡ ³ôÀº °÷.
  • high energy phosphate bond
    °í¿¡³ÊÁö ÀÎ»ê °áÇÕ
    ÀÎ»ê °áÇÕ ÇüŰ¡ ³ôÀº ¿¡³ÊÁö·Î ÀÌ·ç¾îÁø »óÅÂ. ÀÌ °áÇÕÀº ¾Æ³×³ë½Å »ïÀλê. Æ÷½ºÆ÷Å©·¹¾ÆÆ¾. ´ç ´ë»çÀÇ Áß°£»ê¹° µî¿¡ Á¸ÀçÇÑ´Ù.
  • high energy radiation
    °í¿¡³ÊÁö ¹æ»ç¼±
    ³ôÀº ¿¡³ÊÁöÀÇ ¹æ»ç¼±À» ¹æÃâÇÏ´Â °Í.
  • high fever
    °í¿­
    ³ôÀº ¿­.
  • high frequency
    °íºóµµ, °íÁÖÆÄ
    ¿¡³ÊÁö°¡ ÀÚÁÖ ¹ß»ýµÇ´Â °Í. ºóµµ°¡ ³ôÀº °Í.
  • high frequency heating
    °íÁÖÆÄ °¡¿­
  • high frequency wave
    °íÁÖÆÄ
  • high intensity proton flow
    °í°­µµ ¾çÀÚÀ¯µ¿
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
high mannose oligosaccharide <biochemistry> A subset of the N glycan chains that are added post translationally to certain asparagine residues of secreted or membrane proteins in eukaryotic cells, contain 5-9 mannose residues, but lack the sialic acid terminated antennae of the so called complex type.
(18 Nov 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
mannosyl-oligosaccharide 1,2-alpha-mannosidase <enzyme> Cleaves off terminal alpha-1,2-linked mannose residues resulting in the oligosaccharide man(9)glcnac(2)
Registry number: EC 3.2.1.113
Synonym: alpha-d-mannosidase I, mannosidase I, man9-mannosidase, man9-alpha-mannosidase, alpha 1,2-mannosidase, 1,2-alpha-d-mannosidase, msds protein
(26 Jun 1999)
mannosyl-oligosaccharide 1,3 - 1,6-alpha-mannosidase <enzyme> Removes alpha-1,3- and alpha-1,6-mannosyl residues during post-translational modification of glycoproteins; amino acid sequence of gmii (drosophila) given in second source; genbank x77652
Registry number: EC 3.2.1.114
Synonym: mannosidase II, alpha-d-mannosidase II, 1,3-(1,6-)mannosyl-oligosaccharide alpha-d-mannohydrolase, golgi alpha-mannosidase II, gmii gene product
(26 Jun 1999)
phosphatidylglycerol - membrane-oligosaccharide glycerophosphotransferase <enzyme> Transfers phosphoglycerol residues from phosphatidylglycerol to membrane-derived oligosaccharides of E coli
Registry number: EC 2.7.8.20
Synonym: phosphoglycerol transferase I, phosphoglyceroltransferase, phosphoglycerol transferase
(26 Jun 1999)
cycloinulo-oligosaccharide fructanotransferase <enzyme> Converts inulin into cycloinulo-oligosaccharides
Registry number: EC 2.4.1.-
Synonym: cioft, cftase, cycloinulooligosaccharide fructanotransferase
(26 Jun 1999)
dolichol phosphate glucose-dolichol diphosphate oligosaccharide glucosyltransferase <enzyme> Can also use dolichol-p-galactose as donor
Registry number: EC 2.4.1.-
Synonym: dolichol-p-glucose-dolichol-p-p-oligosaccharide glucosyltransferase, dolichol-pp-oligosaccharide glucosyltransferase (ii), dolichol-p-p-oligosaccharide glucosyltransferase (i), dol-p-p-oligosaccharide glycosyltransferase, dppo-glucosyltransferase, dolichyl-p-glucose-man(9)(glcnac)2-pp-dolichol glucosyltransferase
(26 Jun 1999)
oligosaccharide <chemistry> A saccharide of a small number of component sugars, either O or N linked to the next sugar. Number of component sugars not rigorously defined.
(18 Nov 1997)
oligosaccharide 2-O-sulfatase <enzyme> Hydrolyzes the 2-o-sulfate of the disaccharide 4-deoxy-2-o-sulfato-alpha-l-threo-hex-4-enopyranosyluronic acid-(1-4)-2-deoxy-2-sulfamido-6-o-sulfato-d-glucose from heparin
Registry number: EC 3.1.6.-
Synonym: flavobacterium heparinum 2-o-sulphatase, heparo-2-o-sulfatase
(26 Jun 1999)
oligosaccharide dehydrogenase <enzyme> Commercial preparation from staphylococcus which catalyses oxidation of reducing sugars such as glucose, galactose, fructose, mannose, maltose, lactose, maltotriose, maltotetraose, maltopentaose and maltohexaose
Registry number: EC 1.1.-
(26 Jun 1999)
oligosaccharide-diphosphodolichol pyrophosphatase <enzyme> From yeast microsomal membranes; hydrolyses the pyrophosphate bond of oligosaccharide-pyrophosphodolichol into oligosaccharide phosphates plus dolicholphosphate
Registry number: EC 3.6.1.44
Synonym: ols-pp-dol pyrophosphatase, oligosaccharide-pyrophosphodolichol pyrophosphatase
(26 Jun 1999)
alpha-D-mannose-beta-1,2-N-acetylglucosaminyltransferase <enzyme> Absolute specificity for terminal branched mannosyl residues of glycolipids
Registry number: EC 2.4.1.-
Synonym: udpgnac-1,2-magtransferase
(26 Jun 1999)
GDP-mannose - cellobiosyl-diphosphopolyprenol mannosyltransferase <enzyme> Catalyses the transfer of an alpha-mannosyl residue from GDP-mannose to cellobiosyl-diphosphopolyprenol to produce mannosylalpha1-3-cellobiosyl-p-p-polyprenol; genbank u22511
Registry number: EC 2.4.1.-
Synonym: GDP-mannose - cellobiosyl-p-p-polyprenol alpha-mannosyltransferase, acea gene product
(26 Jun 1999)
GDP-mannose mannosyl hydrolase <enzyme> Hydrolyzes GDP-mannose or GDP-glucose to GDP and respective hexose; has little or no activity on other nucleotides, dinucleotides, nucleotide sugars or sugar phosphates; member of the mutt family; mw about 18 kD; genbank l11721
Registry number: EC 3.2.1.-
Synonym: e. Coli orf1.9 product, yefc gene product
(26 Jun 1999)
GDP mannose polyisoprenylphosphate mannosyltransferase <enzyme> From aspergillus niger van tieghem; all polyprenylphosphates from c15 to c120 were acceptors except retinylphosphate
Registry number: EC 2.4.1.-
Synonym: polyprenylphosphate mannosyltransferase
(26 Jun 1999)
mannitol - mannose 1-oxidoreductase <enzyme> Isolated from celeriae root tips; catalyses the nad-dependent oxidation of mannitol to mannose not to fructose; strongly inhibited by NADH and sensitive to alterations of nad-NADH ratio. Do not confuse with mannitol dehydrogenase (EC 1.1.1.67) which is a 2-oxidoreductase which converts mannitol to fructose
Registry number: EC 1.1.1.-
Synonym: mannitol 1-dehydrogenase
(26 Jun 1999)
mannose <chemical> A hexose or fermentable monosaccharide and isomer of glucose from manna, the ash fraxinus ornus and related plants.
Chemical name: Mannose
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • breast-high
    °¡½¿±îÁö ³ôÀÌÀÇ
  • high
    ³ôÀº,°í±ÞÀÇ,³ôÀÌ
  • high time
    ²À ¾Ë¸ÂÀº ¶§
  • high-colored
    ¼±¸íÇÑ »öÁ¶ÀÇ
  • high-coloured
    ¼±¸íÇÑ »öÁ¶
  • high-muck-a-muck
    ³ôÀº »ç¶÷
  • high-muckety-muck
    ³ôÀº »ç¶÷
  • high-spirited
    ±â¿îÂù
  • high-tone
    °¡¶ôÀÌ ³ôÀº
  • high-toned
    °¡¶ôÀÌ ³ôÀº
  • High Dutch
    =High German
  • High Street
    Å«(¹øÈ­ÇÑ) °Å¸®
  • Lord High Chancellor
    ´ë¹ý°ü
  • Middle High German
    Áß¼¼(Áß±â) °íÁö µ¶ÀϾî(12-15¼¼±â)
  • Old High German
    =GERMAN
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á